In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2
Seyyed Sasan Mousavi(Shiraz University), Raffaele Capasso(University of Naples Federico II), İsmail Çeli̇k(Erciyes University), Akbar Karami(Shiraz University), Tahereh Movahhed Haghighi(Iranian Research Organization for Science and Technology), Sefren Geiner Tumilaar(Sam Ratulangi University), Duygu Ağagündüz(Gazi University), Trina Ekawati Tallei(Sam Ratulangi University), Fatimawali Fatimawali(Sam Ratulangi University), Shafi Mahmud(University of Rajshahi), Talha Bin Emran(Brown University), Rinaldi Idroes(Universitas Syiah Kuala)
Cited by 65
Related Papers
Antidiabetic Potential of Medicinal Plants and Their Active Components
|Biomolecules|2019|721
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
|Frontiers in Oncology|2022|531
Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study
|Scientifica|2020|272
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation
|Frontiers in Cellular and Infection Microbiology|2022|241